• 1. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 2. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 3. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 4. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 5. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161

Introduction to 3-propyl-1H-indol-6-ol (CAS No. 820960-40-5)

3-propyl-1H-indol-6-ol, with the chemical formula C??H??NO, is a significant compound in the field of pharmaceutical chemistry and medicinal biology. This heterocyclic organic molecule belongs to the indole family, which has garnered considerable attention due to its diverse biological activities and potential applications in drug development. The compound’s unique structural features, including a propyl substituent at the 3-position and a hydroxyl group at the 6-position of the indole ring, contribute to its distinct chemical properties and biological interactions.

The synthesis of 3-propyl-1H-indol-6-ol involves multi-step organic reactions that highlight the compound’s complexity and the precision required in its preparation. The indole core is a well-known scaffold in medicinal chemistry, often serving as a foundation for designing molecules with therapeutic potential. The propyl group enhances the lipophilicity of the molecule, making it more suitable for membrane interactions, while the hydroxyl group introduces polarity and hydrogen bonding capabilities, which are crucial for binding to biological targets.

Recent advancements in computational chemistry have enabled more efficient virtual screening of indole derivatives like 3-propyl-1H-indol-6-ol. High-throughput virtual screening (HTVS) combined with molecular docking techniques has identified this compound as a promising candidate for further pharmacological investigation. Studies suggest that it may exhibit inhibitory effects on certain enzymes and receptors, making it a valuable lead compound for drug discovery programs targeting neurological and inflammatory disorders.

One of the most intriguing aspects of 3-propyl-1H-indol-6-ol is its potential role in modulating biological pathways associated with cancer metabolism. Emerging research indicates that indole derivatives can influence key metabolic enzymes such as tryptophan 2,3-dioxygenase (TDO) and indoleamine 2,3-dioxygenase (IDO), which are critical in regulating immune responses and tumor microenvironment dynamics. The hydroxyl group in 3-propyl-1H-indol-6-ol may enhance its ability to interact with these enzymes, potentially leading to novel therapeutic strategies.

In vitro studies have demonstrated that 3-propyl-1H-indol-6-ol exhibits dose-dependent effects on various cell lines, including some that are resistant to conventional chemotherapeutic agents. These findings are particularly noteworthy because they suggest that the compound may overcome multidrug resistance (MDR) by targeting specific pathways involved in cancer cell survival. Additionally, its structural similarity to known bioactive indoles like tryptophan derivatives positions it as a candidate for structure-based drug design (SBDD), where computational models are used to optimize its pharmacokinetic and pharmacodynamic properties.

The pharmacokinetic profile of 3-propyl-1H-indol-6-ol is another area of active investigation. Preliminary data suggest that it has moderate solubility in both aqueous and lipid environments, which is advantageous for formulating oral or parenteral dosage forms. However, further studies are needed to assess its metabolic stability and potential for drug-drug interactions. Techniques such as mass spectrometry (MS) and nuclear magnetic resonance (NMR) spectroscopy have been employed to elucidate its metabolic pathways and degradation products, providing insights into how it is processed within biological systems.

The role of natural products in inspiration for synthetic chemists cannot be overstated. Many indole derivatives found in plants have been used as starting points for developing synthetic analogs with enhanced bioactivity. 3-propyl-1H-indol-6-ol, while not directly derived from a known natural product, shares structural motifs with several bioactive compounds isolated from sources like *Catharanthus roseus* and *Withania somnifera*. These natural products have been extensively studied for their pharmacological properties, reinforcing the importance of indole-based scaffolds in medicinal chemistry.

Future directions in research on 3-propyl-1H-indol-6-ol include exploring its potential as an adjuvant therapy alongside existing treatments for chronic diseases. For instance, its ability to modulate immune responses might make it useful in combination with immunotherapy regimens for cancer patients. Additionally, investigating its effects on central nervous system (CNS) disorders is an exciting prospect given the growing interest in indole derivatives as neuroprotective agents.

The development of novel analytical methods has also been instrumental in advancing research on 3-propyl-1H-indol-6-ol. High-performance liquid chromatography (HPLC) coupled with UV detection or mass spectrometry has allowed researchers to quantify this compound accurately in complex mixtures. Such techniques are essential for optimizing synthetic routes and ensuring batch-to-batch consistency during pharmaceutical production.

In conclusion,3-propyl-1H-indol-6-ol (CAS No. 820960-40-5) represents a promising avenue for pharmaceutical innovation due to its unique structural features and demonstrated biological activities. Its potential applications span multiple therapeutic areas, including oncology, immunology, and neurology. As research continues to uncover new insights into its mechanisms of action,3-propyl-1H-indol-6-ol is poised to play a significant role in shaping future drug discovery efforts within the pharmaceutical industry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)